STAAR Surgical Co Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
STAAR Surgical Co (STAA) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $324.00 thousand for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-12
- STAAR Surgical Co right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-07-03 was $324.00K, a 80.11% decline year-over-year.
- STAAR Surgical Co right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-04-03 was $449.00K, a 47.70% increase year-over-year.
- STAAR Surgical Co right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-01-02 was $1.85M, a 186.67% increase year-over-year.
- STAAR Surgical Co right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-26 was $91.00K, a 97.86% decline year-over-year.
- STAAR Surgical Co right-of-use asset obtained in exchange for operating lease liability for fiscal 2026 was $3.87M, a 53.81% decline from fiscal 2024.
- STAAR Surgical Co right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $8.38M, a 1.33% decline from fiscal 2023.
- STAAR Surgical Co right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $8.50M, a 197.13% increase from fiscal 2022.
- STAAR Surgical Co right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $2.86M, a 90.23% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-07-03 | $324.00K 10-Q · filed 2026-08-12 | $773.00K 10-Q · filed 2026-08-12 | $2.62M derived: sum of 3 quarters · filed 2026-08-12 | $2.71M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-04-03 | $449.00K 10-Q · filed 2026-05-13 | $2.30M derived: sum of 2 quarters · filed 2026-05-13 | $2.39M derived: sum of 3 quarters · filed 2026-05-13 | $4.02M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-01-02 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.94M derived: sum of 2 quarters · filed 2026-03-03 | $3.57M derived: sum of 3 quarters · filed 2026-08-12 | $3.87M 10-K · filed 2026-03-03 |
| 2025-09-26 | $91.00K 10-Q · filed 2025-11-05 | $1.72M derived: sum of 2 quarters · filed 2026-08-12 | $2.02M 10-Q · filed 2025-11-05 | $2.67M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-27 | $1.63M 10-Q · filed 2026-08-12 | $1.93M 10-Q · filed 2026-08-12 | $2.58M derived: sum of 3 quarters · filed 2026-08-12 | $6.83M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-28 | $304.00K 10-Q · filed 2026-05-13 | $949.00K derived: sum of 2 quarters · filed 2026-05-13 | $5.20M derived: sum of 3 quarters · filed 2026-05-13 | $7.19M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-27 | $645.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $4.90M derived: sum of 2 quarters · filed 2026-03-03 | $6.89M derived: sum of 3 quarters · filed 2026-03-03 | $8.38M 10-K · filed 2026-03-03 |
| 2024-09-27 | $4.25M 10-Q · filed 2025-11-05 | $6.25M derived: sum of 2 quarters · filed 2025-11-05 | $7.74M 10-Q · filed 2025-11-05 | $8.24M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-28 | $1.99M 10-Q · filed 2025-08-06 | $3.49M 10-Q · filed 2025-08-06 | $3.98M derived: sum of 3 quarters · filed 2026-03-03 | $8.56M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-29 | $1.50M 10-Q · filed 2025-05-07 | $1.99M derived: sum of 2 quarters · filed 2026-03-03 | $6.57M derived: sum of 3 quarters · filed 2026-03-03 | $8.08M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-29 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $5.08M derived: sum of 2 quarters · filed 2026-03-03 | $6.59M derived: sum of 3 quarters · filed 2026-03-03 | $8.50M 10-K · filed 2026-03-03 |
| 2023-09-29 | $4.58M 10-Q · filed 2024-10-30 | $6.09M derived: sum of 2 quarters · filed 2024-10-30 | $8.00M 10-Q · filed 2024-10-30 | $9.69M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $1.51M 10-Q · filed 2024-08-07 | $3.42M 10-Q · filed 2024-08-07 | $5.11M derived: sum of 3 quarters · filed 2025-02-21 | $5.24M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $1.91M 10-Q · filed 2024-05-07 | $3.60M derived: sum of 2 quarters · filed 2025-02-21 | $3.73M derived: sum of 3 quarters · filed 2025-02-21 | $5.81M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-30 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $1.82M derived: sum of 2 quarters · filed 2025-02-21 | $3.90M derived: sum of 3 quarters · filed 2025-02-21 | $2.86M 10-K · filed 2025-02-21 |
| 2022-09-30 | $126.00K 10-Q · filed 2023-11-06 | $2.21M derived: sum of 2 quarters · filed 2023-08-02 | $1.17M 10-Q · filed 2023-11-06 | $12.93M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-01 | $2.08M 10-Q · filed 2023-08-02 | $2.76M 10-Q · filed 2023-08-02 | $12.81M derived: sum of 3 quarters · filed 2024-02-27 | $28.02M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-01 | $675.00K 10-Q · filed 2023-05-03 | $10.72M derived: sum of 2 quarters · filed 2024-02-27 | $25.94M derived: sum of 3 quarters · filed 2024-02-27 | $29.29M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $10.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $25.26M derived: sum of 2 quarters · filed 2024-02-27 | $28.62M derived: sum of 3 quarters · filed 2024-02-27 | $29.27M 10-K · filed 2024-02-27 |
| 2021-10-01 | $15.21M 10-Q · filed 2021-11-03 | $18.57M derived: sum of 2 quarters · filed 2022-11-02 | $19.22M 10-Q · filed 2022-11-02 | $21.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-07-02 | $3.36M 10-Q · filed 2022-08-10 | $4.01M 10-Q · filed 2022-08-10 | $5.79M derived: sum of 3 quarters · filed 2023-02-23 | $8.63M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-04-02 | $651.00K 10-Q · filed 2022-05-04 | $2.43M derived: sum of 2 quarters · filed 2023-02-23 | $5.27M derived: sum of 3 quarters · filed 2023-02-23 | $5.52M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-01-01 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $4.62M derived: sum of 2 quarters · filed 2023-02-23 | $4.87M derived: sum of 3 quarters · filed 2023-02-23 | $4.94M 10-K · filed 2023-02-23 |
| 2020-10-02 | $2.84M 10-Q · filed 2021-11-03 | $3.09M derived: sum of 2 quarters · filed 2021-11-03 | $3.16M 10-Q · filed 2021-11-03 | $3.86M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-07-03 | $249.00K 10-Q · filed 2021-08-04 | $318.00K 10-Q · filed 2021-08-04 | $1.02M derived: sum of 3 quarters · filed 2022-02-23 | $1.16M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-04-03 | $69.00K 10-Q · filed 2021-05-05 | $767.00K derived: sum of 2 quarters · filed 2022-02-23 | $907.00K derived: sum of 3 quarters · filed 2022-02-23 | $2.10M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-01-03 | $698.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $838.00K derived: sum of 2 quarters · filed 2022-02-23 | $2.03M derived: sum of 3 quarters · filed 2022-02-23 | $3.50M 10-K · filed 2022-02-23 |
| 2019-09-27 | $140.00K 10-Q · filed 2020-11-04 | $1.33M derived: sum of 2 quarters · filed 2020-11-04 | $2.80M 10-Q · filed 2020-11-04 | |
| 2019-06-28 | $1.19M 10-Q · filed 2020-08-05 | $2.66M 10-Q · filed 2020-08-05 | ||
| 2019-03-29 | $1.46M 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |